Circulating tumor DNA detection: biological assessment on operating bed to detect residual circulating tumor DNA
Study summary
The aim of this study is to evaluate the interest of residual tumour DNA research in the operating bed after squamous cell carcinoma excision.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Signed informed consent
* Patient with T1 to T4 squamous cell carcinoma of the oral cavity, regardless of lymph node status (all N) M0, operable
* 18 years of age or older
* Member or beneficiary of a social security scheme.
Exclusion Criteria:
* Absence of signed informed consent
* Patient of protected age
* Psychosocial problems
* Not affiliated to or benefiting from a social security scheme
* Previous cervical irradiation
* Pregnant or breast-feeding women
* Patient unable to understand the study for any reason or to comply with the constraints of the trial (language, psychological, geographical problems, etc.).
Primary outcome measure(s)
Residual tumro DNA on operating bed — during the surgery Proportion of patients with residual tumour DNA on the operating bed according to the presence or absence of adverse histological factors
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.